Clinical Trials Logo

Hip Pain Chronic clinical trials

View clinical trials related to Hip Pain Chronic.

Filter by:

NCT ID: NCT03985280 Recruiting - Hip Pain Chronic Clinical Trials

Radiofrequency Versus Intraarticular Local Anesthestic and Steroids Injection for Chronic Hip Pain.

HIPAIN
Start date: June 21, 2018
Phase: Phase 4
Study type: Interventional

Pilot, prospective, randomized study to compare the effectiveness of two techniques against chronic hip pain :cooled radiofrequency on sensory innervation of the hip and intra-articular infiltration of local anesthetic and corticoid. EudraCT protocol code. 2018-000269-36 Promoter / Principal Investigator. Jorge Orduña Valls Name of the person responsible for the monitoring: Nativity Well of the Rose. Design. Pilot, prospective, randomized study to compare the effectiveness of two techniques against chronic pain of hip: radiofrequency cooled on sensory innervation of the hip and intra-articular infiltration of local anesthetic and corticoid. Phase of the trial. Phase IV, efficacy evaluation with respect to standard treatment. Conditions to study. Percentage of subjects with VAS reduction greater than 50% compared to baseline at three months after application of the technique in the two treatment groups. Longer duration of the analgesic effect (defined as a reduction of the VAS greater than 50% basal) at six months from the application of the technique in patients with hip pain. Intervention. Application of radiofrequency cooled on nerve endings of the hip. The standard treatment Non-surgical consists of intra-articular injection of local anesthetic and corticoid. Main and secondary objective. Main goal: - Percentage of subjects with improvement in the two groups defined as VAS reduction greater than 50% with respect to the baseline after three months from the application of the technique. - Compare the persistence of the clinical effect in terms of pain reduction (quantified by a reduction of 50% in the VAS scale compared to the baseline) after six months after the application of the Radiofrequency cooled on sensitive nerve branches of the hip compared to intra-articular injection of local anesthetic and corticoid. Secondary objectives: - Compare the improvement of functional capacity of patients submitted to radiofrequency cooled compared to those treated by intra-articular injection of local anesthetic and corticosteroid measured by the WOMAC and Oxford Hip score scales. - Compare the duration of the clinical improvement in terms of pain reduction quantified by the scale VAS (analog visual scale) per year after the application of both techniques. - To compare the improvement of the quality of life of patients subjected to radiofrequency cooled with respect to those treated by intra-articular injection of local anesthetic and corticosteroid measured by the SF 36 scale. Main valuation variable. Main variable: The evaluation of pain by means of the Visual analogic scale (VAS) A significant reduction in pain will be considered when VAS decreases by> 50% of the baseline value. Secondary variables: - Functional improvement valued by the scales: Oxford Hip score, WOMAC - Better of the quality of life valued by the SF 36 scale - The duration of the clinical effect by means of the duration of improvement of the VAS scale. Population under study and total number of patients. Adult patients with chronic hip pain greater than three months who has not responded to treatment conservative and that is not subsidiary of surgery either by the evolutionary stage or by contraindications related to morbidity terms. Period of follow-up. The duration of the intervention is 12 months from randomization. After the scheduled interventions, patients will be scheduled for monthly follow-up, three, six and twelve months after the procedure

NCT ID: NCT03768895 Completed - Clinical trials for Musculoskeletal Disease

Assement of the Morphological Characteristics of the Hips and Correlating Them With the Pathology Found

Start date: December 20, 2018
Phase:
Study type: Observational [Patient Registry]

The investigators' objective is the anatomical analysis of hips studied through MRI, assessing their morphological characteristics and correlating them with the pathology found. A retrospective search was performed using a database of consecutive reports of 137 adults pelvis MRI examinations obtained at MRI center in Zaragoza. In all the images the investigators are going to measure the ischiofemoral space, quadratus femoris space, cervicodiaphysal angle and femoral version angle. The investigators evaluated different qualitative changes in the signal intensity of the quadratus femoris muscle as normal, edema, fatty infiltration or atrophy, and of the gluteus muscles as tendinopathy or atrophy, too.

NCT ID: NCT03720821 Completed - Chronic Pain Clinical Trials

Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i)

COFLEX-i
Start date: July 16, 2019
Phase: N/A
Study type: Interventional

To determine whether a 5-week computer-based cognitive training intervention results in changes in resting-state functional connectivity (rsFC) within the brain networks.

NCT ID: NCT03590145 Completed - Inguinal Hernia Clinical Trials

Reliability of the Doha Agreement Classification of Groin Pain

Start date: October 25, 2017
Phase:
Study type: Observational

This study will investigate the reproducibility of a clinical diagnostic classification system for groin pain between two different examiners.

NCT ID: NCT03576625 Recruiting - Knee Pain Chronic Clinical Trials

Effect of Buglossoides Oil on Recent Chronic Non-injurious Hip and Knee Pain

Start date: February 10, 2018
Phase: Phase 1
Study type: Interventional

The effect of Buglossoides oil emulsion on the intensity of recent chronic knee and hip pain, on plasma and mononuclear blood cells fatty acid profiles and on whole blood Eicosapentaenoic acid production will be investigated.

NCT ID: NCT03490071 Recruiting - Hip Pain Chronic Clinical Trials

Long-term Follow up of Patients With Longstanding Hip and Groin Pain

Lund LHGP
Start date: January 1, 2018
Phase:
Study type: Observational

In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon.

NCT ID: NCT03351439 Completed - Hip Pain Chronic Clinical Trials

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Start date: April 6, 2018
Phase: N/A
Study type: Interventional

The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the investigators will compare the standard of care (SOC), with routine pain management with a post-operative opioid prescription, to three different groups with multi-modal analgesia (SOC+peri-operative celecoxib, SOC+peri-operative gabapentin, and SOC+post-operative zopiclone). The investigators hypothesize that administration of multi-modal analgesia in all three treatment groups will result in improved post-operative pain control, reduced post-operative narcotic consumption and an overall reduction in post-operative length-of-stay compared to the group receiving treatment as per the standard of care. However, prior to undertaking a large multi-centre study, the investigators need to determine whether the study is feasible from data obtained with this pilot study.

NCT ID: NCT03248934 Completed - Hip Disease Clinical Trials

Patient Performed Examination for Patients With Intra-articular Hip Pain

Start date: July 18, 2017
Phase: N/A
Study type: Interventional

The primary objective of this study is evaluate the diagnostic accuracy of a patient self-administered clinical examination of the hip compared with a traditional clinical examination (i.e. index test).

NCT ID: NCT02947178 Completed - Anesthesia Clinical Trials

Hip Arthroscopy Pain Control Randomized Control Trial (RCT)

Start date: March 1, 2016
Phase: Phase 4
Study type: Interventional

Femoroacetabular impingement is a pathologic process within the hip joint that results from a mechanical discord between the femoral head and neck and the acetabulum that results in chronic hip pain, hip labral tears and early progression of osteoarthritis of the hip.1, 2 Historically an open surgical hip dislocation was performed to treat patients with this condition, however with recent advances in arthroscopy, patients more commonly now undergo arthroscopic hip surgery. From a pain management standpoint, previous attempts to provide peri-operative analgesia included intraarticular or portal analgesic injections. More recently, regional anesthesia techniques are being employed to provide more reliable and longer lasting post-operative pain control.3, 4 Currently, there are several local anesthetics available for regional anesthesia. However, they only provide an average of 12-18 hours of post-operative pain control following a single injection.5 Bupivacaine is a local anesthetic that has been used for many years by multiple routes to control post-operative pain. A new formulation of the medication prolongs the release of the active ingredient after a single injection and has been shown to result in up to 72 hours of post-operative analgesia.6, 7 To the investigator's knowledge, there has not been any studies in the literature comparing a historical control local anesthetic to this new formulation of liposomal bupivacaine via a fascial iliaca regional soft tissue infiltration blockade to provide post operative pain control following hip arthroscopy.

NCT ID: NCT01562366 Completed - Hip Pain Chronic Clinical Trials

Research Study to Compare the Addition of Topaz Micro Debridement to the Standard of Care Surgery

Start date: April 2012
Phase: N/A
Study type: Interventional

Compare the surgical use of Topaz with the Standard Of Care in the treatment of Greater Trochanteric Pain Syndrome (a type of hip pain). The hypothesis is that there is a difference between the two treatment groups.